AXA IM Alts has completed the acquisition of an office building in Berlin from a pharmaceutical company for an undisclosed sum.
The asset manager has stated its intentions to begin a significant repositioning of the building on expiry of the current lease, subject to approvals, and to improve its sustainability credentials.